CLU (clusterin) promotes mitophagic degradation of MSX2 through an AKT-DNM1L/Drp1 axis to maintain SOX2-mediated stemness in oral cancer stem cells-Reference-Cited by-同舟云学术

CLU (clusterin) promotes mitophagic degradation of MSX2 through an AKT-DNM1L/Drp1 axis to maintain SOX2-mediated stemness in oral cancer stem cells

Published:2023-03-06 Issue:8 Volume:19 Page:2196-2216
ISSN:1554-8627
Container-title:Autophagy
language:en
Short-container-title:Autophagy

Author:

Praharaj Prakash P.¹,Patra Srimanta¹,Mishra Soumya R.¹,Mukhopadhyay Subhadip¹,Klionsky Daniel J.²^ORCID,Patil Shankargouda³⁴,Bhutia Sujit K.¹^ORCID

Affiliation:

1. Cancer and Cell Death Laboratory, Department of Life Science, National Institute of Technology Rourkela, Rourkela, Odisha, India

2. Life Sciences Institute and Department of Molecular, Cellular and Developmental Biology, University of Michigan, Ann Arbor, MI, USA

3. College of Dental Medicine, Roseman University of Health Sciences, South Jordan, UTAH, USA

4. Centre of Molecular Medicine and Diagnostics (COMManD), Saveetha Dental College & Hospitals, Saveetha Institute of Medical and Technical Sciences , Saveetha University, Chennai, India

Funder

Department of Biotechnology, Government of India

and the NIH

Publisher

Informa UK Limited

Subject

Cell Biology,Molecular Biology

Link

https://www.tandfonline.com/doi/pdf/10.1080/15548627.2023.2178876

Reference48 articles.

1. Cancer Statistics, 2021

2. Grand Challenges in Oral Cancers

3. Cisplatin-enriching cancer stem cells confer multidrug resistance in non-small cell lung cancer via enhancing TRIB1/HDAC activity

4. Cisplatin Induces Bmi-1 and Enhances the Stem Cell Fraction in Head and Neck Cancer

5. RXRα-enriched cancer stem cell-like properties triggered by CDDP in head and neck squamous cell carcinoma (HNSCC)

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Regulation of mitochondrial quality control of intestinal stem cells in homeostasis and diseases;Antioxidants & Redox Signaling;2024-09-03

2. Bridging the gap between epigenetics and cisplatin resistance: Implications for oral cancer management;Oral Oncology Reports;2024-09

3. Clusterin attenuates blood–brain barrier damage and cognitive impairment by inhibiting astrocyte aging in mice with sepsis-associated encephalopathy;NeuroReport;2024-07-05

4. Targeting cellular mitophagy as a strategy for human cancers;Frontiers in Cell and Developmental Biology;2024-07-05

5. Cancer stem cells: advances in knowledge and implications for cancer therapy;Signal Transduction and Targeted Therapy;2024-07-05